Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Silence Therapeutics (SLN) Receivables - Other (2019)

Historic Receivables - Other for Silence Therapeutics (SLN) over the last 1 years, with Q4 2019 value amounting to $34714.6.

  • Silence Therapeutics' Receivables - Other changed N/A to $34714.6 in Q4 2019 from the same period last year, while for Dec 2019 it was $34714.6, marking a year-over-year change of. This contributed to the annual value of $34474.6 for FY2019, which is N/A changed from last year.
  • Silence Therapeutics' Receivables - Other amounted to $34714.6 in Q4 2019.
  • Silence Therapeutics' 5-year Receivables - Other high stood at $34714.6 for Q4 2019, and its period low was $34714.6 during Q4 2019.